| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1736-1788, 2018 | 7376 | 2018 |
| Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study L Dandona, R Dandona, GA Kumar, DK Shukla, VK Paul, K Balakrishnan, ... The Lancet 390 (10111), 2437-2460, 2017 | 1000 | 2017 |
| The tuberculosis cascade of care in India’s public sector: a systematic review and meta-analysis R Subbaraman, RR Nathavitharana, S Satyanarayana, M Pai, BE Thomas, ... PLoS medicine 13 (10), e1002149, 2016 | 285 | 2016 |
| Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 MV Murhekar, T Bhatnagar, S Selvaraju, K Rade, V Saravanakumar, ... Indian Journal of Medical Research 152 (1-2), 48-60, 2020 | 221 | 2020 |
| SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey MV Murhekar, T Bhatnagar, S Selvaraju, V Saravanakumar, ... The Lancet Global Health 9 (3), e257-e266, 2021 | 208 | 2021 |
| Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ... The Lancet Global Health 4 (11), e806-e815, 2016 | 206 | 2016 |
| SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021 MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ... International Journal of Infectious Diseases 108, 145-155, 2021 | 144 | 2021 |
| Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models NA Menzies, GB Gomez, F Bozzani, S Chatterjee, N Foster, IG Baena, ... The Lancet global health 4 (11), e816-e826, 2016 | 93 | 2016 |
| Assessing tuberculosis control priorities in high-burden settings: a modelling approach JF Vesga, TB Hallett, MJA Reid, KS Sachdeva, R Rao, S Khaparde, ... The Lancet Global Health 7 (5), e585-e595, 2019 | 82 | 2019 |
| 99DOTS: a low-cost approach to monitoring and improving medication adherence A Cross, N Gupta, B Liu, V Nair, A Kumar, R Kuttan, P Ivatury, A Chen, ... Proceedings of the Tenth International Conference on Information and …, 2019 | 75 | 2019 |
| Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ... PLoS medicine 18 (12), e1003877, 2021 | 73 | 2021 |
| Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control … MM Parmar, KS Sachdeva, PK Dewan, K Rade, SA Nair, R Pant, ... PloS one 13 (4), e0193903, 2018 | 70 | 2018 |
| Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22-April 30, 2020 P Abraham, N Aggarwal, GR Babu, S Barani, B Bhargava, T Bhatnagar, ... Indian Journal of Medical Research 151 (5), 424-437, 2020 | 64 | 2020 |
| National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance MS Kumar, T Bhatnagar, P Manickam, VS Kumar, K Rade, N Shah, S Kant, ... Indian Journal of Medical Research 151 (5), 419-423, 2020 | 62 | 2020 |
| Airborne infection control in India: baseline assessment of health facilities MM Parmar, KS Sachdeva, K Rade, M Ghedia, A Bansal, SB Nagaraja, ... indian journal of tuberculosis 62 (4), 211-217, 2015 | 41 | 2015 |
| The prevalence of tuberculosis infection in India: a systematic review and meta-analysis A Chauhan, M Parmar, GC Dash, H Solanki, S Chauhan, J Sharma, ... Indian Journal of Medical Research 157 (2&3), 135-151, 2023 | 39 | 2023 |
| Tapping private health sector for public health program? Findings of a novel intervention to tackle TB in Mumbai, India V Shibu, S Daksha, C Rishabh, K Sunil, G Devesh, S Lal, S Jyoti, R Kiran, ... indian journal of tuberculosis 67 (2), 189-201, 2020 | 36 | 2020 |
| Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India PK Moonan, SA Nair, R Agarwal, VK Chadha, PK Dewan, UD Gupta, ... BMJ global health 3 (5), e001135, 2018 | 32 | 2018 |
| Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data N Arinaminpathy, D Batra, N Maheshwari, K Swaroop, L Sharma, ... BMC Infectious Diseases 19, 1-7, 2019 | 30 | 2019 |
| Direct observation of treatment provided by a family member as compared to non-family member among children with new tuberculosis: A pragmatic, non-inferiority, cluster … PV Dave, AN Shah, PB Nimavat, BB Modi, KR Pujara, P Patel, K Mehariya, ... PLoS One 11 (2), e0148488, 2016 | 29 | 2016 |
